Pricing Log in Create free account

MIRA Pharmaceuticals, Inc. (MIRA) vs Nasus Pharma Ltd. (NSRX)

MIRA Pharmaceuticals, Inc. and Nasus Pharma Ltd. are both Drug Manufacturers General companies. Nasus Pharma Ltd. is the larger, with a market value of $37.1M against $27.7M — 1.3× the size. Across the 7 metrics below, Nasus Pharma Ltd. leads on 5 and MIRA Pharmaceuticals, Inc. on 2.

Valuation

Metric MIRA NSRX Drug Manufacturers General median
P/E n/m — 24.54
P/S n/m — 3.39
P/B 3.24 n/m 5.00
Price to free cash flow n/m n/m 16.55
EV/EBITDA n/m n/m 13.82
EV/Sales n/m n/m 4.03
Earnings yield (226.03%) — 2.98%
Free cash flow yield (17.52%) 0.00% 4.46%

Profitability

Metric MIRA NSRX Drug Manufacturers General median
Gross margin — — 72.77%
Operating margin 0.00% — 18.77%
Net margin 0.00% — 8.27%
Free cash flow margin 0.00% 0.00% 17.18%
Return on equity (710.85%) 0.00% 5.87%
Return on assets (684.27%) 0.00% 2.57%
Return on invested capital (12,016.10%) 0.00% 6.11%

Growth

Metric MIRA NSRX Drug Manufacturers General median
Revenue growth (TTM) — — 6.66%
EPS growth (last fiscal year) (164.71%) (231.82%) 21.81%
Revenue growth, 5-year CAGR — — 4.75%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric MIRA NSRX Drug Manufacturers General median
Debt to equity 0.00 0.00 0.63
Current ratio 200.19 8.77 1.32
Net debt to EBITDA 1.05 0.26 1.15

Dividend

Metric MIRA NSRX Drug Manufacturers General median
Dividend yield — — 2.33%
Payout ratio — — 0.59

Size

Metric MIRA NSRX Drug Manufacturers General median
Market cap 27.65m 37.06m 123.73b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack